midatohealth.com

What It Is

Midato Health is a digital health company under CedarBridge Group. Its core product, ShareApprove, is designed for healthcare, social services, and health data interoperability scenarios. The goal is to turn paper consent forms, SDoH screenings, and health forms into computable, searchable, and auditable digital workflows. The product emphasizes that “data privacy and data sharing are not mutually exclusive,” using patient-driven consent management to support cross-organization care coordination and value-based care.

Core Features and Integrations

ShareApprove can invite users via SMS links to view, complete, and sign almost any form. It supports granular, non-binary consent choices and allows individuals to change or revoke authorization at any time. The platform can collect structured data for querying, reporting, and analytics, while also retaining the source of consent, its current storage location, and lifecycle events to create a complete provenance record. It is also positioned as an enterprise-grade Master Consent Index—a unified source of consent preferences across providers and care settings. The official website explicitly mentions use of the HL7 FHIR standard and integration with existing systems such as EHRs, member enrollment, care coordination, care management, and interoperability platforms. White-label embedding is also supported.

Pricing, Security, and Deployment

The official website does not disclose plans, pricing, billing models, free tiers, or trial information, and only provides options to book a demo or contact sales. For deployment, the site describes it as a platform-agnostic SaaS, with technology and data hosted in the United States; self-hosting is not mentioned. In terms of security and compliance, the product emphasizes health data privacy, compliant sharing, reduced risk of unauthorized disclosure, and compliance support through provenance and consent lifecycle records. However, the website does not show specific certifications such as HIPAA or SOC 2.

Pros and Cons

Its strengths are a highly focused healthcare privacy authorization use case, support for HL7 FHIR, API-based querying of consent status and documents, white-labeling, and integration with existing workflows. It is well suited to organizations that need to share sensitive health data across systems. The drawbacks are limited transparency around commercialization, insufficient public information on permission structures, backend collaboration, API documentation, and security certifications. Buyers should confirm these details through a demo and due diligence before procurement.

Who It’s For and Access from China

It is best suited for U.S. healthcare providers, health information exchanges, EHR vendors, care coordination platforms, social service programs, and health registry systems. Access from China is unknown. Even if accessible, the product is clearly designed around U.S. healthcare interoperability and privacy regulations, so Chinese organizations should carefully assess network connectivity, cross-border data transfer, payment, language, and local compliance. Alternatives to consider include DocuSign, Adobe Acrobat Sign, Redox, as well as China-based providers such as 法大大, 上上签, 腾讯电子签, and local healthcare IT vendors.